Director Declaration

3 October 2019 16:00 BST

Director Declaration

AstraZeneca PLC (the Company) today announced, pursuant to Listing Rule 9.6.14 R (2), that Pascal Soriot, Chief Executive Officer of the Company, is a director of Viela Bio, Inc. which recently completed an initial public offering and listed on the Nasdaq Global Market.

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular,

Source: Director Declaration

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.